51 / 86
Study 309
: Randomized, open-label, multicenter, phase 3
study of eribulin versus dacarbazine in patients with
leiomyosarcoma and adipocytic sarcoma:
Health-related
quality-of-life results
Gelderblom H, et al. Presented at ESMO 2015 Congress, Vienna Schöffski P, et al. Lancet. 2016 Apr 16;387(10028):1629-37
Schöffski P, et al. Lancet. 2016 Apr 16;387(10028):1629-37